alpha-1 proteinase inhibitor, Prolastin-C (cont.)

Pharmacy Author:
Medical Editor:

Patients, family members, or caregivers can be trained to administer alpha1-proteinase inhibitor at home.

DRUG INTERACTIONS: Information on drug-drug interaction is not found in the medical literature and is not provided by the manufacturer.

PREGNANCY: Alpha-1 proteinase inhibitor has not been adequately evaluated in pregnant women. Due to the lack of conclusive safety data, alpha-1 proteinase inhibitor should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Alpha-1 proteinase inhibitor is classified as FDA pregnancy risk category C.

NURSING MOTHERS: It is not known if alpha-1 proteinase inhibitor is excreted in breast milk. Because many drugs enter human milk and can potentially cause harm to the nursing infant, alpha-1 proteinase inhibitor should be used cautiously in nursing mothers.

REFERENCE: FDA Prescribing Information


Medically Reviewed by a Doctor on 3/20/2015


Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index